NEW YORK (TheStreet) -- Last year venture capitalist Vinod Khosla wrote a white paper that was a call to arms on medical IT, a field I've been following since 2006.
The big story back then was of electronic health records, or EHRs, which would transform care by giving doctors data on their patients. I naively assumed this would benefit mainstream tech companies, like Microsoft (MSFT) and Google (GOOG), which had the necessary technology. They assumed as much, too.
We were wrong. Both those companies exited the market with their financial tails between their legs.
The 2009 Recovery Act included $19.2 billion in stimulus for EHRs, and politically-connected CEOs like Glen Tullman of Allscripts (MDRX) assumed they would win the money by selling software as a service, or SaaS, requiring less upfront cost to doctors and clinics, along with faster upgrades done centrally.The argument made sense, but Tullman, too, was wrong. Since December, he has also been out as CEO, as Forbes reported. Shares in Allscripts now sell for little more than they did when health reform was first proposed. Instead the gains have gone to incumbent medical technology firms like Cerner (CERN), which has quadrupled in value under this president, and McKesson (MCK), which has more than doubled while adding a handsome dividend. The new Allscripts CEO is a former Cerner executive. More importantly, medical care inflation still outstrips that in the general economy, according to MetricMash. Overall prices from October 2009 through October 2012 were up 7%, medical costs were up 10.5%. Khosla confronted doctors directly in September, as Wired reported, saying "healthcare is like witchcraft and just based on tradition," rather than driven by data. He said 80% of what doctors do could be done better by computers. Khosla blames a natural resistance to change on the part of doctors, device makers, and others in the industry. At the Health Care Blog, David Liu didn't disagree with Khosla's diagnosis, but called his entrepreneurial mind set "problematic and dangerous." My own reading of Khosla paints a different picture. The current market failures are driving people out of the market, he writes, into the arms of companies like Walgreens (WAG) and CVS Caremark (CVS), which already have clinics manned by nurses and physicians' assistants -- assisted by technology -- in hundreds of stores around the country.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV